• About Us
  • Science
    • Vaccines
    • Antibodies
  • Our Pipeline
  • Investors
    • Share Info
    • Financial Info
    • Documents & Presentations
    • Company Profile
    • Advisors
    • Corporate Governance
    • 2024 Capital Raise
  • Resources
    • News
    • Publications
  • Contact Us
    • Find a trial
    • Become an Investigator

Scancell is focused on developing novel immunotherapies for the treatment of cancer and was founded in 1996 based on research led by Professor Lindy Durrant at the University of Nottingham in the UK.

  • Follow
  • Follow

About Us
Leadership Team
Science
Our Pipeline
News
Contact Us
Find a Trial
Become an Investigator

VACCINES

ImmunoBody®
Moditope®

ANTIBODIES

GlyMab®
AvidiMab®

Investors
Company Profile
Advisors
Corporate Governance
Documents & Presentations
Share Information
Financial Information

Copyright © 2025 Scancell | Website Designed & Developed by Identity Creative | Privacy & Cookie Policy